Pharma’s other congressional problem

It’s been two years and one regime change since Novartis got itself perilously involved with President Trump’s personal lawyer, Michael Cohen. And yet here we are.

Cohen, testifying before Congress yesterday, got asked about the time Novartis paid him $1.2 million for advisory services and said the company “came to me based on my knowledge of the enigma Donald Trump” and got six interactions out of it.

Novartis said it considers its Cohen entanglement a closed matter, and the congressman who asked about the affair didn’t place any blame on the company. But, as STAT’s Matthew Herper writes, the whole ordeal has become a headache that just won’t go away.

Read more.